We use cookies to design our website optimally for you. By confirming the button "Accept" you agree to the use of cookies. By clicking the checkboxes below, you can select which cookie categories you want to allow. Clicking the "Show more" button provides a description of each category. For further information, please refer to our privacy policy.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
On our website, we may also integrate services from third parties such as Google, Matomo, YouTube, Vimeo or Facebook. The data is collected using cookies or similar technologies and transmitted to third parties who provide their services independently.
11:00 | B-cell lymphoproliferations in the bone marrow without defining molecular features
B-cell lymphoproliferations in the bone marrow without defining molecular featuresÂ
Chairs: Konnie Hebeda and Mats Ehinger
- Sa Wang (Houston, USA) - Myeloid/lymphoid neoplasms with TK gene fusions – new entities
- Marco Herling (Leipzig, Germany) - Histiocytic and dendritic cell neoplasms - the clinical perspective
